SCHEMBL20053536

SCHEMBL20053536

CC(C)(F)CN1CCC(COc2cnc(-c3ccc(C(=O)N4CCCCC4)cc3F)cn2)CC1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.40
ALOX5AP P20292 5/20 0.39
FEN1 P39748 5/20 0.39
HPGD P15428 3/20 0.39
CYP2D6 P10635 1/20 0.38
MGLL Q99685 1/20 0.37
PDK2 Q15119 1/20 0.36
PARP1 P09874 1/20 0.36
PARP2 Q9UGN5 1/20 0.36
KCNH2 Q12809 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
LIPE Q05469 1/20 0.36
PDE4B Q07343 1/20 0.35
ADRB2 P07550 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15537622 0.91 ALOX5AP (0.46) GPR119ALOX5APFEN1PDK2
SCHEMBL15538128 0.91 ALOX5AP (0.46) GPR119ALOX5APFEN1PDK2
SCHEMBL15537623 0.91 ALOX5AP (0.46) GPR119ALOX5APFEN1PDK2
SCHEMBL15538136 0.90 ALOX5AP (0.44) GPR119ALOX5APFEN1PDK2PARP1
SCHEMBL15538137 0.90 ALOX5AP (0.44) GPR119ALOX5APFEN1PDK2PARP1
SCHEMBL15538976 0.89 GPR119 (0.42) GPR119ALOX5APFEN1KCNH2
SCHEMBL20053594 0.88 GPR119 (0.46) GPR119HRH3ADRB2
SCHEMBL15538429 0.87 GPR119 (0.41) GPR119ALOX5APFEN1LIPE
SCHEMBL20053577 0.87 GPR119 (0.45) GPR119HPGDCYP2D6KCNH2HRH3
SCHEMBL15538342 0.87 PDK2 (0.41) GPR119ALOX5APFEN1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed